Impact of the adherence to medical treatment on the main urinary metabolic disorders in patients with kidney stones

To assess the effect of the adherence to medical treatment on urinary parameters in the 24-h metabolic study of patients with kidney stones. A retrospective, longitudinal, descriptive, and observational study was carried out by reviewing the hospital electronic medical record from 2014 to 2018. The...

ver descrição completa

Detalhes bibliográficos
Autores: Manzo, Braulio Omar, Cabrera, Jose David, Emiliani, Esteban|||0000-0003-4488-0022, Sánchez, Hector Manuel, Eisner, Brian Howard, Torres, Jose Ernesto
Formato: artículo
Fecha de publicación:2020
País:España
Recursos:Universitat Autònoma de Barcelona
Repositorio:Dipòsit Digital de Documents de la UAB
Idioma:inglés
OAI Identifier:oai:ddd.uab.cat:248891
Acesso em linha:https://ddd.uab.cat/record/248891
https://dx.doi.org/urn:doi:10.1016/j.ajur.2020.07.002
Access Level:acceso abierto
Palavra-chave:Kidney stones
Renal stones
Metabolic disorders
Medical treatment
Citrate
Oxalate
Lithiasis
Descrição
Resumo:To assess the effect of the adherence to medical treatment on urinary parameters in the 24-h metabolic study of patients with kidney stones. A retrospective, longitudinal, descriptive, and observational study was carried out by reviewing the hospital electronic medical record from 2014 to 2018. The adherence to drug treatment was measured 6 months after its initiation, and the numerical values of the metabolic studies were compared. Wilcoxon tests were performed to compare the difference before and after treatment. Ninety patients were evaluated, with 73.3% of adherence. The 180-day overall adherence rate was 61.2% in patients treated with a single drug and 85.4% in patients treated with multiple drugs. There is a statistically significant increase in citrate levels in patients with good adherence in comparison with non-adherent patients (p =0.031 vs. p =0.528). Medical treatment and dietary measures in patients with kidney stones have an initial impact at 6 months on the values of the main urinary metabolic alterations that predispose to calculi formation; the most significant is seen in those patients with adherence to medical treatment for hypocitraturia.